Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
ViroMissile, Inc.
Eisai Inc.
Jonsson Comprehensive Cancer Center
SAPU NANO (US) LLC
Guerbet
University of Washington